Author:
de Kraker Jan,Hoefnagel Kees A.,Verschuur Arnauld C.,van Eck Berthe,van Santen Hanneke M.,Caron Huib N.
Reference16 articles.
1. Matthay KK, Villablanca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. NEJM 1999;341:1165–73.
2. High-dose Melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG-1) by the European Neuroblastoma study group;Pritchard;Pediatr Blood Cancer,2005
3. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised trial;Berthold;Lancet Oncology,2005
4. Radionuclide diagnosis and therapy of neural crest tumours using iodine-131 metaiodobenzylguanidine;Hoefnagel;J Nucl Med,1987
5. Phase I dose escalation of iodine-131-methaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study;Mathay;J Clin Oncol,2006
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献